Albemarle (NYSE:ALB – Free Report) had its price objective hoisted by Mizuho from $112.00 to $128.00 in a research report report published on Thursday, Benzinga reports. The brokerage currently has a neutral rating on the specialty chemicals company’s stock. Several other analysts have also recently weighed in on ALB. Royal Bank of Canada lowered their […]